Expertise in Mitochondrial Conglomerate Dynamics for Oncology, Rehabilitation & Precision Medicine (Mito-Passport)

Mitolab (Kazakhstan) provides high-level expertise in Translational Mitochondrial Medicine. We have pioneered the assessment of the "Mitochondrial Conglomerate" — viewing the mitochondrial network as a single functional organelle within immune cells to predict and manage clinical outcomes.

Our Core Expertise Includes:

• Mito-Passport Technology: A proprietary diagnostic framework for monitoring systemic bioenergetics via neutrophil mitochondrial dynamics.

• Clinical Validation: Expertise in reducing chemotherapy toxicity (by 40%) and improving survival rates in advanced oncology (26.7% mortality reduction).

• Extracorporeal Detoxification: Expertise in integrating mitochondrial monitoring with apheresis and advanced ICU protocols at the Military Clinical Hospital.

• Immune-Metabolic Rehabilitation: Developing personalized recovery strategies for oncology and post-critical care patients.

What We Offer to MSCA Doctoral Networks (DN) & Staff Exchanges (SE):

1. Clinical Research Site: Access to the Military Clinical Hospital’s ICU and Detoxification Unit for real-world technology validation.

2. Training Environment: A unique intersectoral setting for PhD fellows to study molecular biophysics in a clinical context.

3. Data Resources: Long-term clinical datasets (2,400+ patients) for bioinformatic and prognostic modeling.

We are ready to act as a Non-Academic (Industrial) Partner for consortia focusing on Life Sciences, Aging research, and Precision Medicine.